Pāriet uz galveno navigāciju Pāriet uz meklēšanu Pāriet uz galveno saturu

Biomarkers, matrices and analytical methods targeting human exposure to chemicals selected for a European human biomonitoring initiative

  • Katrin Vorkamp*
  • , Argelia Castaño
  • , Jean Philippe Antignac
  • , Luis D. Boada
  • , Enrique Cequier
  • , Adrian Covaci
  • , Marta Esteban López
  • , Line S. Haug
  • , Monika Kasper-Sonnenberg
  • , Holger M. Koch
  • , Octavio Pérez Luzardo
  • , Agnese Arāja
  • , Loïc Rambaud
  • , Maria Teresa Pinorini
  • , Gabriele Sabbioni
  • , Cathrine Thomsen
  • *Šī darba korespondējošais autors
  • Aarhus University
  • Instituto de Salud Carlos III
  • École nationale vétérinaire, agroalimentaire et de l'alimentation, Nantes-Atlantique
  • University of Las Palmas de Gran Canaria
  • Norwegian Institute of Public Health
  • University of Antwerp
  • Institute for Prevention and Occupational Medicine of the German Social Accident Insurance - Institute of the Ruhr-University
  • Santé publique France
  • Alpine Institute of Chemistry and Toxicology

Zinātniskās darbības rezultāts: Devums žurnālam › Zinātniskais raksts (žurnālā) › koleģiāli recenzēts

143 Atsauces (Scopus)

Kopsavilkums

The major purpose of human biomonitoring is the mapping and assessment of human exposure to chemicals. The European initiative HBM4EU has prioritized seven substance groups and two metals relevant for human exposure: Phthalates and substitutes (1,2-cyclohexane dicarboxylic acid diisononyl ester, DINCH), bisphenols, per- and polyfluoroalkyl substances (PFASs), halogenated and organophosphorous flame retardants (HFRs and OPFRs), polycyclic aromatic hydrocarbons (PAHs), arylamines, cadmium and chromium. As a first step towards comparable European-wide data, the most suitable biomarkers, human matrices and analytical methods for each substance group or metal were selected from the scientific literature, based on a set of selection criteria. The biomarkers included parent compounds of PFASs and HFRs in serum, of bisphenols and arylamines in urine, metabolites of phthalates, DINCH, OPFRs and PAHs in urine as well as metals in blood and urine, with a preference to measure Cr in erythrocytes representing Cr (VI) exposure. High performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) was the method of choice for bisphenols, PFASs, the HFR hexabromocyclododecane (HBCDD), phenolic HFRs as well as the metabolites of phthalates, DINCH, OPFRs and PAHs in urine. Gas chromatographic (GC) methods were selected for the remaining compounds, e.g. GC-low resolution MS with electron capture negative ionization (ECNI) for HFRs. Both GC–MS and LC-MS/MS were suitable for arylamines. New developments towards increased applications of GC–MS/MS may offer alternatives to GC–MS or LC-MS/MS approaches, e.g. for bisphenols. The metals were best determined by inductively coupled plasma (ICP)-MS, with the particular challenge of avoiding interferences in the Cd determination in urine. The evaluation process revealed research needs towards higher sensitivity and non-invasive sampling as well as a need for more stringent quality assurance/quality control applications and assessments.

OriģinālvalodaAngļu
Raksta numurs106082
ŽurnālsEnvironment International
Sējums146
DOIs
Publikācijas statussPublicēts - janv. 2021

OECD Zinātnes nozare

  • 1.4 Ķīmija

Nospiedums

Uzziniet vairāk par pētniecības tēmām “Biomarkers, matrices and analytical methods targeting human exposure to chemicals selected for a European human biomonitoring initiative”. Kopā tie veido unikālu nospiedumu.

Citēt šo